Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological Treatment of Insomnia.

Literature DB >> 26609210

Pharmacological Treatment of Insomnia.

Janette D Lie, Kristie N Tu, Diana D Shen, Bonnie M Wong.

Abstract

Up to 70 million U.S. adults have chronic sleep and wakefulness disorders. Therapies may include prescription medications approved by the Food and Drug Administration, off-label treatments, over-the-counter drugs, and herbal therapies.

Entities: Disease

Year: 2015 PMID： 26609210 PMCID： PMC4634348

Source DB: PubMed Journal: P T ISSN： 1052-1372

71 in total

1. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

Authors: S M Troy; I Lucki; M A Unruh; W H Cevallos; C A Leister; P T Martin; P M Furlan; R Mangano
Journal: J Clin Psychopharmacol Date: 2000-06 Impact factor: 3.153

2. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.

Authors: David J Greenblatt; Eric Legangneux; Jerold S Harmatz; Estelle Weinling; Jon Freeman; Kathleen Rice; Gary K Zammit
Journal: J Clin Pharmacol Date: 2006-12 Impact factor: 3.126

Review 3. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia.

Authors: Kunal V Patel; Anthony V Aspesi; Kirk E Evoy
Journal: Ann Pharmacother Date: 2015-02-09 Impact factor: 3.154

4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

Authors: Thomas Roth; Christina Soubrane; Laurence Titeux; James K Walsh
Journal: Sleep Med Date: 2006-07-03 Impact factor: 3.492

Review 5. Treating primary insomnia - the efficacy of valerian and hops.

Authors: Shanah Salter; Sonya Brownie
Journal: Aust Fam Physician Date: 2010-06

6. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

Authors: Matthew W Johnson; Patricia E Suess; Roland R Griffiths
Journal: Arch Gen Psychiatry Date: 2006-10

7. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.

Authors: J Fry; M Scharf; R Mangano; M Fujimori
Journal: Int Clin Psychopharmacol Date: 2000-05 Impact factor: 1.659

8. An aqueous extract of valerian influences the transport of GABA in synaptosomes.

Authors: M S Santos; F Ferreira; A P Cunha; A P Carvalho; T Macedo
Journal: Planta Med Date: 1994-06 Impact factor: 3.352

9. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.

Authors: Alan Lankford; Roberta Rogowski; Beal Essink; Elizabeth Ludington; H Heith Durrence; Thomas Roth
Journal: Sleep Med Date: 2011-12-24 Impact factor: 3.492

10. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.

Authors: Gary Zammit; Milton Erman; Sherry Wang-Weigand; Stephen Sainati; Jeffrey Zhang; Thomas Roth
Journal: J Clin Sleep Med Date: 2007-08-15 Impact factor: 4.062

21 in total

1. Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening.

Authors: Patricia Murphy; Dinesh Kumar; Gary Zammit; Russell Rosenberg; Margaret Moline
Journal: J Clin Sleep Med Date: 2020-02-06 Impact factor: 4.062

2. Subjective-Objective Sleep Discrepancy in Older Adults With MCI and Subsyndromal Depression.

Authors: Elizabeth A DiNapoli; Marie Anne Gebara; Terry Kho; Meryl A Butters; Ariel G Gildengers; Steven M Albert; Mary Amanda Dew; Kirk I Erickson; Charles F Reynolds; Jordan F Karp
Journal: J Geriatr Psychiatry Neurol Date: 2017-09-27 Impact factor: 2.680

3. The Association Between Habitual Sleep Duration and Blood Pressure Control in United States (US) Adults with Hypertension.

Authors: Everlyne G Ogugu; Sheryl L Catz; Janice F Bell; Christiana Drake; Julie T Bidwell; James E Gangwisch
Journal: Integr Blood Press Control Date: 2022-05-25

4. Medication Use Reported by Individuals With Tinnitus Who Are Seeking Internet-Based Psychological Interventions.

Authors: Vinaya Manchaiah; Alicia Brazelton; Hansapani Rodrigo; Eldré W Beukes; Marc A Fagelson; Gerhard Andersson; Meghana V Trivedi
Journal: Am J Audiol Date: 2021-10-27 Impact factor: 1.636

5. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.

Authors: Shanna L Burke; Tianyan Hu; Christine E Spadola; Tan Li; Mitra Naseh; Aaron Burgess; Tamara Cadet
Journal: Sleep Med Date: 2018-09-20 Impact factor: 3.492

6. The association between micronutrient status and sleep quality in patients with depression: a case-control study.

Authors: Haitham Jahrami; Eman Alekri; Ahmed S BaHammam; Ali Alsalman; Nicola Luigi Bragazzi; Omar Alhaj; Zahra Saif
Journal: Sleep Breath Date: 2020-10-17 Impact factor: 2.816

7. Effects of physical activity programs on sleep outcomes in older adults: a systematic review.

Authors: J Vanderlinden; F Boen; J G Z van Uffelen
Journal: Int J Behav Nutr Phys Act Date: 2020-02-05 Impact factor: 6.457

8. Impact of improvement of sleep disturbance on symptoms and quality of life in patients with functional dyspepsia.

Authors: Fumihiko Nakamura; Shiko Kuribayashi; Fumio Tanaka; Noriyuki Kawami; Yasuhiro Fujiwara; Katsuhiko Iwakiri; Motoyasu Kusano; Toshio Uraoka
Journal: BMC Gastroenterol Date: 2021-02-18 Impact factor: 3.067

9. Marijuana versus evidence-based treatments for sleep and relaxation: A cross-sectional study of use and dose modification following involuntary job loss.

Authors: Iva Skobic; Gabriella R Apolinar; Stuart F Quan; Patricia L Haynes
Journal: Sleep Health Date: 2020-08-02

10. Simplified drug efficacy screening system for sleep-disorder drugs using non-human primates.

Authors: Keita Sakai; Akiyoshi Ishikawa; Yuri Mizuno; Takehiro Maki; Yasuhiro Oda; Eiki Takahashi
Journal: Heliyon Date: 2020-03-04